Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03983993
Title Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NIPAVect)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Indications

colorectal cancer

Therapies

Niraparib + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST